Strategic selection of MDM2 inhibitors enhances the efficacy of FAK inhibition in mesothelioma based on TP53 genotype.

Saved in:
Bibliographic Details
Title: Strategic selection of MDM2 inhibitors enhances the efficacy of FAK inhibition in mesothelioma based on TP53 genotype.
Authors: Ning, Xuerao1,2 (AUTHOR), Nguyễn, Thảo Thi Thanh1,3,4 (AUTHOR), Morinaga, Takao1 (AUTHOR), Tada, Yuji5 (AUTHOR), Shimada, Hideaki6 (AUTHOR), Hiroshima, Kenzo7,8,9 (AUTHOR), Yamaguchi, Naoto2 (AUTHOR), Tagawa, Masatoshi7,10 (AUTHOR) mtagawachiba@gmail.com
Source: PLoS ONE. 2/23/2026, Vol. 21 Issue 2, p1-20. 20p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19326203
DOI:10.1371/journal.pone.0343551